|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
QUARTERLY REPORT OF ATHEROGENICS, INC. PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30,
2000.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 56,367,187
<SECURITIES> 0
<RECEIVABLES> 873,420
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 57,973,138
<PP&E> 3,114,531
<DEPRECIATION> 1,418,210
<TOTAL-ASSETS> 59,848,802
<CURRENT-LIABILITIES> 4,013,221
<BONDS> 0
0
0
<COMMON> 103,578,866
<OTHER-SE> (47,837,639)
<TOTAL-LIABILITY-AND-EQUITY> 59,848,802
<SALES> 0
<TOTAL-REVENUES> 6,060,485
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 17,308,542
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (806,520)
<INCOME-PRETAX> (10,441,537)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (10,441,537)
<EPS-BASIC> (1.66)
<EPS-DILUTED> (1.66)
</TABLE>
|
|